Fusion partners for peptide production
US10118956B2 · kind B2 · utility
0Cited by
38References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2015 |
| Grant date | Nov 6, 2018 |
| Priority date | — |
| Expiry date | Mar 23, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to the field of medicine, in particular, to the production of large amounts of a soluble recombinant polypeptide as part of a fusion protein comprising an N-terminal fusion partner linked to the polypeptide of interest.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.